Sowell Financial Services LLC Madrigal Pharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$97.2 - $137.59 $17,496 - $24,766	-180 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$108.54 - $125.2 $434 - $500	-4 Reduced 2.17%	180 $23,000
Q4 2020 Jan 13, 2021	BUY	$110.06 - $133.7 $7,043 - $8,556	64 Added 53.33%	184 $20,000
Q3 2020 Nov 12, 2020	SELL	$99.78 - $124.21 $3,592 - $4,471	-36 Reduced 23.08%	120 $14,000
Q2 2020 Aug 13, 2020	SELL	$60.13 - $125.71 $18,039 - $37,713	-300 Reduced 65.79%	156 $18,000
Q1 2020 May 12, 2020	SELL	$66.76 - $93.49 $17,023 - $23,839	-255 Reduced 35.86%	456 $30,000
Q4 2019 Feb 07, 2020	BUY	$84.28 - $118.5 $51,495 - $72,403	611 Added 611.0%	711 $64,000
Q3 2019 Nov 14, 2019	BUY	$84.4 - $106.53 $8,440 - $10,653	100 New	100 $9,000

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.8B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.